Brokerages expect that Castlight Health, inc. (NYSE:CSLT) will announce $30.96 million in sales for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Castlight Health, inc.’s earnings, with the highest sales estimate coming in at $31.05 million and the lowest estimate coming in at $30.90 million. Castlight Health, inc. reported sales of $23.59 million during the same quarter last year, which indicates a positive year over year growth rate of 31.2%. The firm is scheduled to issue its next earnings report on Monday, August 14th.

According to Zacks, analysts expect that Castlight Health, inc. will report full year sales of $30.96 million for the current financial year, with estimates ranging from $132.30 million to $134.27 million. For the next fiscal year, analysts forecast that the firm will post sales of $167.32 million per share, with estimates ranging from $155.10 million to $177.32 million. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that follow Castlight Health, inc..

Castlight Health, inc. (NYSE:CSLT) last released its earnings results on Wednesday, April 26th. The software maker reported ($0.05) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.05). The firm had revenue of $27.70 million during the quarter, compared to analyst estimates of $28.40 million. Castlight Health, inc. had a negative net margin of 48.72% and a negative return on equity of 43.23%. The business’s revenue was up 22.0% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.13) EPS.

A number of brokerages have recently commented on CSLT. Zacks Investment Research downgraded shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research report on Thursday, April 27th. Cowen and Company reissued a “market perform” rating and issued a $4.00 price objective on shares of Castlight Health, inc. in a research report on Wednesday, March 8th. Morgan Stanley downgraded shares of Castlight Health, inc. from an “equal weight” rating to an “underweight” rating and decreased their price objective for the company from $4.00 to $3.75 in a research report on Friday, May 12th. ValuEngine downgraded shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research report on Friday, May 19th. Finally, Chardan Capital began coverage on shares of Castlight Health, inc. in a research report on Tuesday, June 6th. They issued a “buy” rating and a $4.50 price objective for the company. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. Castlight Health, inc. currently has an average rating of “Hold” and a consensus target price of $4.44.

In other Castlight Health, inc. news, insider Giovanni M. Colella sold 11,456 shares of the company’s stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $3.75, for a total transaction of $42,960.00. Following the transaction, the insider now owns 88,094 shares in the company, valued at $330,352.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Priya Jain sold 7,858 shares of the company’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $3.65, for a total transaction of $28,681.70. Following the transaction, the chief accounting officer now owns 20,000 shares in the company, valued at approximately $73,000. The disclosure for this sale can be found here. Insiders have sold a total of 37,051 shares of company stock worth $140,343 over the last three months. Insiders own 24.38% of the company’s stock.

Several hedge funds have recently made changes to their positions in the stock. Stifel Financial Corp raised its position in Castlight Health, inc. by 4.3% in the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock valued at $133,000 after buying an additional 1,500 shares during the last quarter. TIAA CREF Investment Management LLC raised its position in shares of Castlight Health, inc. by 2.1% in the first quarter. TIAA CREF Investment Management LLC now owns 108,032 shares of the software maker’s stock worth $394,000 after buying an additional 2,210 shares in the last quarter. Teachers Advisors LLC raised its position in shares of Castlight Health, inc. by 8.1% in the fourth quarter. Teachers Advisors LLC now owns 62,781 shares of the software maker’s stock worth $311,000 after buying an additional 4,717 shares in the last quarter. Citadel Advisors LLC raised its position in shares of Castlight Health, inc. by 5.8% in the first quarter. Citadel Advisors LLC now owns 104,457 shares of the software maker’s stock worth $381,000 after buying an additional 5,696 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Castlight Health, inc. by 2.7% in the first quarter. Geode Capital Management LLC now owns 306,367 shares of the software maker’s stock worth $1,118,000 after buying an additional 8,057 shares in the last quarter. Institutional investors own 39.35% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “$30.96 Million in Sales Expected for Castlight Health, inc. (CSLT) This Quarter” was reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/06/21/30-96-million-in-sales-expected-for-castlight-health-inc-cslt-this-quarter.html.

Castlight Health, inc. (NYSE CSLT) opened at 4.05 on Wednesday. The firm’s 50-day moving average is $3.81 and its 200-day moving average is $3.84. Castlight Health, inc. has a 52-week low of $3.05 and a 52-week high of $5.50. The firm’s market cap is $528.58 million.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Get a free copy of the Zacks research report on Castlight Health, inc. (CSLT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.